Francisella

Published on 08/02/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3101 times

Francisella

Blood, chocolate, and Thayer-Martin agars can be used for the primary isolation of organisms belonging to the genus Francisella. Francisella organisms are facultative, intracellular pathogens that require cysteine, cystine, or another sulfhydryl and a source of iron for enhanced growth. They thus require a complex medium for isolation and growth.

General Characteristics

Organisms belonging to the genus Francisella are faintly staining, tiny, gram-negative coccobacilli that are oxidase and urease negative, catalase-positive, nonmotile, non–spore forming, strict aerobes. The taxonomy of this genus continues to be in flux. Current members of the genus share greater than 97% identity based on 16SrRNA sequence analysis. The most current proposed taxonomy is summarized in Table 38-1. For the most part, different subspecies are associated with different geographic regions.

TABLE 38-1

Most Recent Taxonomy of the Genus Francisella and Key Characteristics

Organism Primary Region Disease in Humans Requires Cystine/Cysteine
F. tularensis subsp. tularensis North America (United States and Canada) Most severe: Tularemia (all forms, see Table 38-2) +
F. tularensis subsp. holartica Europe, former Soviet Union, Japan, North America Least severe: Tularemia (all forms) +
F. tularensis subsp. mediasiatica Kazakhstan, Uzbekistan Severe: Tularemia +
F. noatunensis (formerly F. philomiragia subsp. noatunensis) North and South America Emerging pathogen of fish; no human infections identified _
F. novicida North America Mild illness; virulent in immunocompromised patients _
F. philomiragia (formerly Yersinia philomiragia) North America Mild illness; virulent only in immunocompromised individuals and near-drowning victims _

image

Epidemiology and Pathogenesis

Francisellaceae are widely distributed throughout the environment. F. tularensis is the agent of human and animal tularemia. F. novicida and F. philomiragia are present in the environment and are opportunistic human pathogens. Worldwide in distribution, F. tularensis is carried by many species of wild rodents, rabbits, beavers, and muskrats in North America. Humans become infected by handling the carcasses or skin of infected animals; by inhaling infective aerosols or ingesting contaminated water; through insect vectors (primarily deerflies and ticks in the United States); and by being bitten by carnivores that have themselves eaten infected animals. Some evidence indicates that francisellae can persist in waterways, possibly in association with amebae.

Most cases in the United States are sporadic, occurring during the summer months, and most cases are seen in the states of South Dakota, Arkansas, Missouri, and Oklahoma.

The capsule of F. tularensis appears to be a necessary component for expression of full virulence, allowing the organism to avoid immediate destruction by polymorphonuclear neutrophils. In addition to being extremely invasive, F. tularensis is an intracellular parasite that can survive in the cells of the reticuloendothelial system, where it resides after a bacteremic phase. Granulomatous lesions may develop in various organs. Humans are infected by fewer than 50 organisms by either aerosol or cutaneous routes. F. tularensis subsp. tularensis is the most virulent for humans, with an infectious dose of less than 10 colony forming units. F. philomiragia has been isolated from several patients, many of whom were immunocompromised or victims of near-drowning incidents. The organism is present in animals and ground water.

Spectrum of Disease

The disease associated with F. tularensis, known as tularemia, is recognized worldwide. In the United States the clinical manifestations have been referred to as rabbit fever, deer fly fever, and market men’s disease. The clinical manifestation depends on the mode of transmission, the virulence of the infecting organism, the immune status of the host, and the length of time from infection to diagnosis and treatment. The typical clinical presentation after inoculation of F. tularensis through abrasions in the skin or by arthropod bites includes the development of a lesion at the site and progresses to an ulcer; lymph nodes adjacent to the site of inoculation become enlarged and often necrotic. Once the organism enters the bloodstream, patients become systemically ill with high temperature, chills, headache, and generalized aching. Clinical manifestations of infection with F. tularensis range from mild and self-limiting to fatal; they include glandular, ulceroglandular, oculoglandular, oropharyngeal, systemic, and pneumonic forms. These clinical presentations are briefly summarized in Table 38-2.

TABLE 38-2

Clinical Manifestations of Francisella tularensis Infection

Types of Infection Clinical Manifestations and Description
Ulceroglandular Common; ulcer and lymphadenopathy; rarely fatal
Glandular Common; lymphadenopathy; rarely fatal
Oculoglandular Conjunctivitis, lymphadenopathy
Oropharyngeal Ulceration in the oropharynx
Systemic (typhoidal) tularemia Acute illness with septicemia; 30% to 60% mortality rate; no ulcer or lymphadenopathy
Pneumonic tularemia Acquired by inhalation of infectious aerosols or by dissemination from the bloodstream; pneumonia; most serious form of tularemia

Laboratory Diagnosis

F. tularensis is a Biosafety Level 2 pathogen, a designation that requires technologists to wear gloves and to work in a biologic safety cabinet (BSC) when handling clinical material that potentially harbors this agent. The organism is designated Biosafety Level 3 when the laboratorian is working with cultures; therefore, a mask is recommended for the handling of all clinical specimens and is very important for preventing aerosol acquisition of F. tularensis. Because tularemia is one of the most common laboratory-acquired infections, most microbiologists do not attempt to work with infectious material from suspected patients. It is recommended that specimens be sent to reference laboratories or state or other public health laboratories that are equipped to handle Francisella spp.

Specimen Collection, Transport, and Processing

The most common specimens submitted to the laboratory are scrapings from infected ulcers, lymph node biopsies, and sputum. Whole blood is an acceptable specimen for all types of tularemia; however, false-negative results may occur during early stages of disease. Serum is generally collected from all patients early in disease and during convalescence. The blood should be separated from the serum as soon as possible, preferably within 24 hours, and may be stored at 2° to 8°C for up to 10 days. If long-term storage is required, the serum may be frozen. To minimize the loss of viable organisms, samples should be transported to the laboratory within 24 hours. If specimens are to be held longer than 24 hours, specimens should be refrigerated in Amie’s transport medium. F. tularensis should remain viable for up to 7 days stored at ambient temperature in Amie’s medium. Swab specimens should be placed in Amie’s transport media containing charcoal. Specimens for molecular testing should be placed in guanidine isothiocyanate buffer for up to 1 month.

Specimen collection for the identification of F. tularensis is highly dependent on the type of clinical manifestation. A detailed description of the recommended type of specimen associated with the patient’s clinical presentation is presented in Table 38-3. In light of recent events and concerns about bioterrorism, laboratories must keep in mind that isolation of F. tularensis from blood cultures might be considered a potential bioterrorist attack; F. tularensis is considered one of the Select Biological Agents of Human Disease (see Chapter 80).

TABLE 38-3

Recommended Specimen Type Based on Clinical Manifestation

  CLINICAL MANIFESTATION
Ulceroglandular Glandular Oculoglandular Oropharyngeal Typhoidal Pneumonic
Whole blood X X X X X X
Serum X X X X X X
Pharyngeal swabs, bronchial/tracheal washes or aspirates, sputum, transthoracic lung aspirates, and pleural fluid       X X X
Swabs from visible lesions X   X      
Aspirates from lymph nodes or lesions X X X      

image

Direct Detection Methods

Gram staining of clinical material is of little use with primary specimens unless the concentration of organisms is high, as in swabs from wounds or ulcers, tissues, and respiratory aspirates. The organisms tend to counterstain poorly with safranin. Replacing safranin with basic fuchsin may enhance identification. Fluorescent antibody stains and immunohistochemical stains are commercially available for direct detection of the organism in lesion smears and tissues and are typically available in reference laboratories. Conventional and real-time polymerase chain reaction (PCR) assays have been developed to detect F. tularensis directly in clinical specimens. Of significance, several patients with clinically suspected tularemia with negative serology and culture had detectable DNA by PCR. Currently most PCR-based assays are unable to discriminate F. tularensis from F. novicida, which limits the value of the epidemiologic data.

Cultivation

Isolation of F. tularensis is difficult. The organism is strictly aerobic and is enhanced by enriched media containing sulfhydryl compounds (cysteine, cystine, thiosulfate or IsoVitaleX) for primary isolation. Two commercial media for cultivation of the organism are available: glucose cystine agar (BBL; Microbiology Systems, Sparks, Maryland) and cystine-heart agar (Difco Laboratories, Detroit, Michigan); both require the addition of 5% sheep or rabbit blood. F. tularensis also may grow on chocolate agar supplemented with IsoVitaleX, the nonselective buffered charcoal-yeast extract agar (BCYE) used for isolation of legionellae, or modified Mueller-Hinton broth and tryptic soy broth supplemented with 1% to 2% IsoVitaleX. Growth is not enhanced by carbon dioxide.

These slow-growing organisms require 2 to 4 days for maximal colony formation; they are weakly catalase positive and oxidase negative. Some strains may require up to 2 weeks to develop visible colonies. F. philomiragia is less fastidious than F. tularensis. Although F. philomiragia does not require cysteine or cystine for isolation, it is similar to F. tularensis in that it is a small, coccobacillary rod that grows poorly or not at all on MacConkey agar. This organism grows well on heart infusion agar with 5% rabbit blood or BCYE agar with or without cysteine. F. tularensis can be detected in commercial blood culture systems in 2 to 5 days; because these organisms Gram stain poorly, an acridine orange stain may be required to visualize the organisms in a positive blood culture bottle.

Approach to Identification

Colonies are transparent, mucoid, and easily emulsified. Although carbohydrates are fermented, isolates should be identified serologically (by agglutination) or by a fluorescent antibody stain. Ideally, isolates should be sent to a reference laboratory for characterization.

F. philomiragia differs from F. tularensis biochemically; F. philomiragia is oxidase-positive by Kovac’s modification, and most strains produce hydrogen sulfide in triple sugar iron agar medium, hydrolyze gelatin, and grow in 6% sodium chloride (no strains of F. tularensis share these characteristics).

In previous reports, problems have been identified in association with Francisella species isolated from clinical specimens. Twelve microbiology employees were exposed to F. tularensis even though bioterrorism procedures were in place; the organism had been isolated from blood, respiratory, and autopsy specimens and grew on chocolate agar. In this situation, multiple cultures were worked up on open benches without any additional personal protective equipment for what had been thought to be most consistent with a Haemophilus species. As a result of this report, microbiologists must be aware of not only the key characteristics of this group of organisms (Box 38-1), but also the possible pitfalls in their identification (e.g., some strains grow well on sheep blood agar; identification kits may incorrectly suggest an identification of Actinobacillus actinomycetemcomitans). If F. tularensis is suspected, all culture Petri dishes should be taped from the top to the bottom in two places to keep them together for safety purposes.

Prevention

The primary means of preventing tularemia is to reduce the possibility of exposure to the etiologic agent in nature, such as by wearing protective clothing to prevent insect bites and by refraining from handling dead animals. An investigative live-attenuated vaccine is available.